Header Logo

Connection

PAVEL SUMAZIN to Animals

Back to Details
This is a "connection" page, showing publications PAVEL SUMAZIN has written about Animals.
PAVEL SUMAZIN
Connection Strength
0.265
Animals
  1. DWE: discriminating word enumerator. Bioinformatics. 2005 Jan 01; 21(1):31-8.
    View in: PubMed
    Score: 0.013
  2. Genetic or pharmacological GHSR blockade has sexually dimorphic effects in rodents on a high-fat diet. Commun Biol. 2024 05 25; 7(1):632.
    View in: PubMed
    Score: 0.013
  3. Deciphering Early-Stage Molecular Mechanisms of Negative Pressure Wound Therapy in a Murine Model. Int J Mol Sci. 2024 Feb 17; 25(4).
    View in: PubMed
    Score: 0.013
  4. A novel treatment strategy utilizing panobinostat for high-risk and treatment-refractory hepatoblastoma. J Hepatol. 2024 Apr; 80(4):610-621.
    View in: PubMed
    Score: 0.013
  5. HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells. Biol Open. 2022 09 15; 11(9).
    View in: PubMed
    Score: 0.012
  6. Kr?ppel-like Factor 4 Supports the Expansion of Leukemia Stem Cells in MLL-AF9-driven Acute Myeloid Leukemia. Stem Cells. 2022 08 25; 40(8):736-750.
    View in: PubMed
    Score: 0.012
  7. MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma. Nat Commun. 2022 06 28; 13(1):3728.
    View in: PubMed
    Score: 0.011
  8. Escalated (Dependent) Oxycodone Self-Administration Is Associated with Cognitive Impairment and Transcriptional Evidence of Neurodegeneration in Human Immunodeficiency Virus (HIV) Transgenic Rats. Viruses. 2022 03 24; 14(4).
    View in: PubMed
    Score: 0.011
  9. CRLF2 overexpression results in reduced B-cell differentiation and upregulated E2F signaling in the Dp16 mouse model of Down syndrome. Exp Hematol. 2022 06; 110:34-38.
    View in: PubMed
    Score: 0.011
  10. CHAF1A Blocks Neuronal Differentiation and Promotes Neuroblastoma Oncogenesis via Metabolic Reprogramming. Adv Sci (Weinh). 2021 10; 8(19):e2005047.
    View in: PubMed
    Score: 0.011
  11. Restoration of the molecular clock is tumor suppressive in neuroblastoma. Nat Commun. 2021 06 28; 12(1):4006.
    View in: PubMed
    Score: 0.011
  12. MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma. Sci Rep. 2021 02 03; 11(1):2967.
    View in: PubMed
    Score: 0.010
  13. Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation. Blood Adv. 2019 12 23; 3(24):4215-4227.
    View in: PubMed
    Score: 0.010
  14. Increases in compulsivity, inflammation, and neural injury in HIV transgenic rats with escalated methamphetamine self-administration under extended-access conditions. Brain Res. 2020 01 01; 1726:146502.
    View in: PubMed
    Score: 0.009
  15. TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma. Am J Pathol. 2019 05; 189(5):1077-1090.
    View in: PubMed
    Score: 0.009
  16. Epitranscriptomics: Correlation of N6-methyladenosine RNA methylation and pathway dysregulation in the hippocampus of HIV transgenic rats. PLoS One. 2019; 14(1):e0203566.
    View in: PubMed
    Score: 0.009
  17. LIN28 Selectively Modulates a Subclass of Let-7 MicroRNAs. Mol Cell. 2018 07 19; 71(2):271-283.e5.
    View in: PubMed
    Score: 0.009
  18. Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma. Neuro Oncol. 2018 03 27; 20(4):506-518.
    View in: PubMed
    Score: 0.009
  19. A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma. Sci Rep. 2017 12 19; 7(1):17751.
    View in: PubMed
    Score: 0.008
  20. A novel humanized mouse lacking murine P450 oxidoreductase for studying human drug metabolism. Nat Commun. 2017 06 28; 8(1):39.
    View in: PubMed
    Score: 0.008
  21. Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia. Nat Commun. 2016 08 30; 7:12642.
    View in: PubMed
    Score: 0.008
  22. Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer. J Hepatol. 2016 08; 65(2):325-33.
    View in: PubMed
    Score: 0.007
  23. The miR-424(322)/503 cluster orchestrates remodeling of the epithelium in the involuting mammary gland. Genes Dev. 2014 Apr 01; 28(7):765-82.
    View in: PubMed
    Score: 0.006
  24. MMTV-Espl1 transgenic mice develop aneuploid, estrogen receptor alpha (ERa)-positive mammary adenocarcinomas. Oncogene. 2014 Nov 27; 33(48):5511-5522.
    View in: PubMed
    Score: 0.006
  25. A molecular signature predictive of indolent prostate cancer. Sci Transl Med. 2013 Sep 11; 5(202):202ra122.
    View in: PubMed
    Score: 0.006
  26. Identification of the human mature B cell miRNome. Immunity. 2009 May; 30(5):744-52.
    View in: PubMed
    Score: 0.005
  27. Tissue-specific regulatory elements in mammalian promoters. Mol Syst Biol. 2007; 3:73.
    View in: PubMed
    Score: 0.004
  28. DNA motifs in human and mouse proximal promoters predict tissue-specific expression. Proc Natl Acad Sci U S A. 2006 Apr 18; 103(16):6275-80.
    View in: PubMed
    Score: 0.004
  29. Mining ChIP-chip data for transcription factor and cofactor binding sites. Bioinformatics. 2005 Jun; 21 Suppl 1:i403-12.
    View in: PubMed
    Score: 0.004
  30. Identifying tissue-selective transcription factor binding sites in vertebrate promoters. Proc Natl Acad Sci U S A. 2005 Feb 01; 102(5):1560-5.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.